Odronextamab, Odronextamab, Odronextamab
R1979-ONC-1625
Phase 2 small_molecule active
Quick answer
Odronextamab, Odronextamab, Odronextamab for B-cell non-Hodgkin lymphoma (NHL) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- B-cell non-Hodgkin lymphoma (NHL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active